Psychedelics Were a Big Winner on Election Night
The psychedelics story has just begun to gain momentum.
We’re already seeing a good deal of clinical studies on psilocybin for example, for the treatment of obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, eating disorders, depression and anxiety.
We’re also just beginning to see broader support in the U.S.
In fact, over the last few months, Denver, Oakland, and Santa Cruz have legalized the use of psilocybin. Earlier this week, Oregon became the first state to legalize psilocybin in a therapeutic setting.
With Measure 109, the psilocybin movement is about overcoming depression, as noted by KATU 2 ABC. In addition, “An estimated 1 in every 5 adults in Oregon is coping with a mental health condition,” 20 doctors and other health care workers wrote in the voters’ pamphlet.